Company intelligence / Profile preview

Excellerate Bioscience

Nottingham, England, United Kingdomexcelleratebio.com ↗

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Excellerate Bioscience provides high-quality molecular and cellular pharmacology services to support drug discovery from early target identification through lead optimization and preclinical candidate characterization. The company has completed over 150 projects for more than 50 clients worldwide, including SMEs, large pharma, and academic partners. It specializes in in vitro pharmacological profiling, mechanism of action studies, phenotypic screening, biomarker validation, and advanced cell-based assays.

Modalities: Small moleculeBiologicGene editingProteinCell-based assay technologiesPhenotypic screening platforms
Industry: Drug Discovery Services

Partnerships

Academic institutions via EU collaborations/grant funding

Beyond the preview

Go deeper on Excellerate Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excellerate Bioscience.

Explore the full profile